Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leena Liljedahl

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Physiological Reports|March 24, 2017
Effects of insulin and the glucagon-like peptide 1 receptor agonist liraglutide on the kidney proteome in db/db miceLeena Liljedahl, Jenny Norlin, James N McGuire, et al.
Cancers|November 27, 2021
Targeted Selected Reaction Monitoring Verifies Histology Specific Peptide Signatures in Epithelial Ovarian CancerLeena Liljedahl, Johan Malmström, Björg Kristjansdottir, et al.
Physiological Reports|February 27, 2019
The impact of the glucagon-like peptide 1 receptor agonist liraglutide on the streptozotocin-induced diabetic mouse kidney proteomeLeena Liljedahl, Maiken H Pedersen, James N McGuire, et al.
Clinical Proteomics|October 21, 2016
N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse modelsLeena Liljedahl, Maiken Højgaard Pedersen, Jenny Norlin, et al.
Nanomaterials (Basel, Switzerland)|January 20, 2021
Fluorescence Signal Enhancement in Antibody Microarrays Using Lightguiding NanowiresDamiano Verardo, Leena Liljedahl, Corinna Richter, et al.
Proteomics. Clinical Applications|February 13, 2021
Identification of a serum biomarker signature associated with metastatic prostate cancerVenera Kuci Emruli, Leena Liljedahl, Ulrika Axelsson, et al.
Biochemistry|December 17, 2008
The intrinsically disordered RNR inhibitor Sml1 is a dynamic dimerJens Danielsson, Leena Liljedahl, Elsa Bárány-Wallje, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Physiological Reports|March 24, 2017
Effects of insulin and the glucagon-like peptide 1 receptor agonist liraglutide on the kidney proteome in db/db miceLeena Liljedahl, Jenny Norlin, James N McGuire, et al.
Cancers|November 27, 2021
Targeted Selected Reaction Monitoring Verifies Histology Specific Peptide Signatures in Epithelial Ovarian CancerLeena Liljedahl, Johan Malmström, Björg Kristjansdottir, et al.
Physiological Reports|February 27, 2019
The impact of the glucagon-like peptide 1 receptor agonist liraglutide on the streptozotocin-induced diabetic mouse kidney proteomeLeena Liljedahl, Maiken H Pedersen, James N McGuire, et al.
Clinical Proteomics|October 21, 2016
N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse modelsLeena Liljedahl, Maiken Højgaard Pedersen, Jenny Norlin, et al.
Nanomaterials (Basel, Switzerland)|January 20, 2021
Fluorescence Signal Enhancement in Antibody Microarrays Using Lightguiding NanowiresDamiano Verardo, Leena Liljedahl, Corinna Richter, et al.
Proteomics. Clinical Applications|February 13, 2021
Identification of a serum biomarker signature associated with metastatic prostate cancerVenera Kuci Emruli, Leena Liljedahl, Ulrika Axelsson, et al.
Biochemistry|December 17, 2008
The intrinsically disordered RNR inhibitor Sml1 is a dynamic dimerJens Danielsson, Leena Liljedahl, Elsa Bárány-Wallje, et al.
Pageof 1